Histone acetylation regulates prostate ductal morphogenesis through a bone morphogenetic protein–dependent mechanism
Open Access
- 17 August 2015
- journal article
- research article
- Published by Wiley in Developmental Dynamics
- Vol. 244 (11) , 1404-1414
Abstract
Background: Epigenetic factors influence stem cell function and other developmental events but their role in prostate morphogenesis is not completely known. We tested the hypothesis that histone deacetylase (HDAC) activity is required for prostate morphogenesis. Results: We identified the presence of class I nuclear HDACs in the mouse urogenital sinus (UGS) during prostate development and found that Hdac 2 mRNA abundance diminishes as development proceeds which is especially evident in prostatic epithelium. Blockade of HDACs with the inhibitor trichostatin A (TSA) decreased the number of prostatic buds formed in UGS explant cultures but not the number of buds undergoing branching morphogenesis. In the latter, TSA promoted an extensive branching phenotype that was reversed by exogenous NOGGIN protein, which functions as a bone morphogenetic protein (BMP) inhibitor. TSA also increased Bmp2 promoter H3K27ac abundance, Bmp2 and Bmp4 mRNA abundance, and the percentage of epithelial cells marked by BMP‐responsive phosphorylated SMAD1/5/8 protein. TSA exposed UGS explants grafted under the kidney capsule of untreated host mice for continued development achieved a smaller size without an obvious difference in glandular histology compared with control treated grafts. Conclusions: These results are consistent with an active role for HDACs in shaping prostate morphogenesis by regulating Bmp abundance. Developmental Dynamics 244:1404–1414, 2015.Keywords
Funding Information
- National Institutes of Health (R01DK099328)
This publication has 41 references indexed in Scilit:
- HDAC inhibitor confers radiosensitivity to prostate stem-like cellsBritish Journal of Cancer, 2013
- Selectively Targeting Prostate Cancer with Antiandrogen Equipped Histone Deacetylase InhibitorsACS Chemical Biology, 2013
- A phase 2 study of intravenous panobinostat in patients with castration-resistant prostate cancerCancer Chemotherapy and Pharmacology, 2013
- Beta-catenin (CTNNB1) induces Bmp expression in urogenital sinus epithelium and participates in prostatic bud initiation and patterningDevelopmental Biology, 2013
- Wnt Inhibitory Factor 1 (Wif1) Is Regulated by Androgens and Enhances Androgen-Dependent Prostate DevelopmentEndocrinology, 2012
- Distinct expression patterns of Sulf1 and Hs6st1 spatially regulate heparan sulfate sulfation during prostate developmentDevelopmental Dynamics, 2012
- Visualization and quantification of mouse prostate development by in situ hybridizationDifferentiation, 2012
- A Secreted BMP Antagonist, Cer1, Fine Tunes the Spatial Organization of the Ureteric Bud Tree during Mouse Kidney DevelopmentPLOS ONE, 2011
- Atlas of Wnt and R‐spondin gene expression in the developing male mouse lower urogenital tractDevelopmental Dynamics, 2011
- A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancerCancer Chemotherapy and Pharmacology, 2010